Accéder au contenu
Merck
  • Molecular evidence for OCT4-induced plasticity in adult human fibroblasts required for direct cell fate conversion to lineage specific progenitors.

Molecular evidence for OCT4-induced plasticity in adult human fibroblasts required for direct cell fate conversion to lineage specific progenitors.

Stem cells (Dayton, Ohio) (2014-04-18)
Ryan Mitchell, Eva Szabo, Zoya Shapovalova, Lili Aslostovar, Kennedy Makondo, Mickie Bhatia
RÉSUMÉ

Here we characterize the molecular and biological requirements for OCT4 plasticity induction in human skin derived fibroblasts (hFibs) that allows direct conversion of cell fate without iPSC formation. Our results indicate that adult hFibs not only require OCT4 but also short-term exposure to reprogramming media (RM) to successfully undergo direct conversion to early hematopoietic and neural progenitor fates. RM was found to be essential in this process and allowed for unique changes in global gene expression specific to the combined effects of OCT4 and treatment with reprogramming media to establish a plastic state. This molecular state of hFib plasticity was distinct from transient expression of a full complement of iPSC reprogramming factors consistent with a lack in molecular hallmarks of iPSC formation. Human Fib-derived OCT4 plastic cells display elevated levels of developmentally related genes associated with multiple lineages, but not those associated with pluripotency. In response to changes in the extracellular environment, plastic OCT4-expressing hFibs further activate genes involved in hematopoietic as well as tripotent neural progenitor biology that allow cell fate conversion. Our study provides a working definition of hFib-induced plasticity using OCT4 and a deconvoluted system to elucidate the process of direct cell fate reprogramming.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
L-acide ascorbique, powder, suitable for cell culture, γ-irradiated
Sigma-Aldrich
L-Glutamine, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
L-acide ascorbique, BioXtra, ≥99.0%, crystalline
Sigma-Aldrich
Forskoline, from Coleus forskohlii, ≥98% (HPLC), powder
Sigma-Aldrich
L-Glutamine, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
L-acide ascorbique, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
Forskoline, For use in molecular biology applications
Sigma-Aldrich
L-acide ascorbique, reagent grade, crystalline
SAFC
L-Glutamine
USP
Acide ascorbique, United States Pharmacopeia (USP) Reference Standard
Supelco
L-acide ascorbique, analytical standard
Sigma-Aldrich
L-acide ascorbique, reagent grade
Sigma-Aldrich
7-Aminoactinomycine D, ~97% (HPLC), powder
Sigma-Aldrich
L-acide ascorbique, meets USP testing specifications
Sigma-Aldrich
L-Glutamine, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
L-acide ascorbique, 99%
Sigma-Aldrich
L-acide ascorbique, FCC, FG
Supelco
L-acide ascorbique, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-acide ascorbique, BioUltra, ≥99.5% (RT)
Sigma-Aldrich
L-acide ascorbique, ACS reagent, ≥99%
Sigma-Aldrich
L-Glutamine
Sigma-Aldrich
L-Glutamine, γ-irradiated, BioXtra, suitable for cell culture
Sigma-Aldrich
2-Phenylindole, technical grade, 95%
Sigma-Aldrich
L-acide ascorbique, puriss. p.a., ACS reagent, reag. ISO, Ph. Eur., 99.7-100.5% (oxidimetric)
L-acide ascorbique, European Pharmacopoeia (EP) Reference Standard
Supelco
Forskoline, analytical standard
Sigma-Aldrich
L-acide ascorbique, puriss. p.a., ≥99.0% (RT)
Sigma-Aldrich
L-acide ascorbique, tested according to Ph. Eur.
Supelco
L-Glutamine, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-acide ascorbique, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland